Top Markets
#1 Pleasing Gold Pleasing Gold +1,496.37%
#2 PulseChain PulseChain +58.12%
#3 Ontology Gas Ontology Gas +37.96%
#4 Merlin's Seal BTC Merlin's Seal BTC +33.44%
#5 BOOK OF MEME BOOK OF MEME +30.66%
#6 Unit Pump Unit Pump +25.83%
#7 Pump.fun Pump.fun +25.83%
#8 Neiro Neiro +25.36%
#9 ConstitutionDAO ConstitutionDAO +23.34%
#10 Collect on Fanable Collect on Fanable +23.27%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals, Inc.

Aerpio Pharmaceuticals, Inc.

ARPO
Rank in Stocks #26440
Aerpio Pharmaceuticals Inc., a biopharmaceutical enterprise headquartered in... Aerpio Pharmaceuticals Inc., a biopharmaceutical enterprise headquartered in Blue Ash, Ohio, currently employs 27 full-time staff. The company's core mission revolves around the research and development of therapeutic solutions for ocular diseases. Its product pipeline is spearheaded by AKB-9778, with two additional programs, AKB-4924 and ARP-1536, also under development. AKB-9778 is a small molecule designed to activate the Tie-2 pathway, intended for the treatment of diabetic retinopathy (DR). AKB-4924, another candidate, functions as a selective stabilizer of hypoxia-inducible factor-1 alpha (HIF-1alpha) and is being investigated for its potential in treating inflammatory bowel disease (IBD). ARP-1536 is a humanized monoclonal antibody that targets the same pathway as AKB-9778. It operates by attaching to the extracellular domain of vascular endothelial protein tyrosine phosphatase (VE-PTP), thereby inhibiting its interaction with Tie-2. As of April 14, 2017, Aerpio had successfully concluded a Phase II clinical trial for AKB-9778, which involved 144 patients with diabetic macular edema. By the same date, a Phase Ia clinical trial for AKB-4924 in healthy volunteers had also been completed.
Share Price
$2.20
Last synced: 2021-08-26
Market Cap
$40.53M
Change (1 day)
-0.90%
Change (1 year)
0.00%
Country
US
Trade Aerpio Pharmaceuticals, Inc. (ARPO)

Category

Healthcare
Dividend history for Aerpio Pharmaceuticals, Inc. (ARPO)
Aerpio Pharmaceuticals, Inc. (stock symbol: ARPO) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Aerpio Pharmaceuticals, Inc. (ARPO) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US